AGI Dermatics gains $5.5M in first round

AGI Dermatics of Freeport, NY has raised $5.5 million in a first round of venture capital. AGI is developing skin cancer prevention therapies along with skin care products. Trevi Health Ventures led the round, which included WHI Group.

- here's the release on AGI

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.